Stay updated on Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Sign up to get notified when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-status notice and the earlier Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T09:57:15.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added a government-funding notice about site operations. Updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T06:53:00.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Glossary feature added to the page. Metadata labels updated (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and the revision version bumped from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T04:48:39.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.3 to v3.3.4, indicating a minor site update with no changes to the study details, enrollment, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:27:44.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-12-23T13:27:13.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision label updated to v3.3.2; no study content or functionality changes are indicated.
    Difference
    0.1%
    Check dated 2025-12-01T17:09:55.000Z thumbnail image

Stay in the know with updates to Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.